RadNet, Inc. (NASDAQ:RDNT) insider John V. Crues sold 15,000 shares of the firm’s stock in a transaction dated Friday, May 11th. The stock was sold at an average price of $13.00, for a total value of $195,000.00. Following the sale, the insider now directly owns 536,607 shares in the company, valued at approximately $6,975,891. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
RadNet opened at $13.00 on Tuesday, according to Marketbeat. The company has a market cap of $631.94 million, a price-to-earnings ratio of 44.83, a PEG ratio of 4.49 and a beta of 0.42. RadNet, Inc. has a 52 week low of $13.00 and a 52 week high of $13.20. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 8.22.
RadNet (NASDAQ:RDNT) last released its quarterly earnings results on Wednesday, May 9th. The medical research company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.04 by ($0.19). The firm had revenue of $231.39 million for the quarter, compared to analyst estimates of $234.32 million. RadNet had a positive return on equity of 21.97% and a negative net margin of 0.66%. The company’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period last year, the firm earned ($0.03) EPS. equities analysts predict that RadNet, Inc. will post 0.37 earnings per share for the current fiscal year.
Several equities research analysts have recently weighed in on RDNT shares. BidaskClub raised RadNet from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 23rd. Zacks Investment Research raised RadNet from a “hold” rating to a “buy” rating and set a $14.00 target price on the stock in a research report on Wednesday, March 21st. FIX began coverage on RadNet in a research report on Wednesday, March 14th. They set a “strong-buy” rating and a $15.00 price target on the stock. Jefferies Group set a $14.00 price target on RadNet and gave the stock a “buy” rating in a research report on Thursday, March 8th. Finally, Raymond James began coverage on RadNet in a research report on Wednesday, March 14th. They set a “strong-buy” rating and a $15.00 price target on the stock. One analyst has rated the stock with a hold rating, three have given a buy rating and two have issued a strong buy rating to the company. RadNet currently has a consensus rating of “Buy” and an average price target of $14.75.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in RDNT. SG Americas Securities LLC acquired a new position in RadNet during the first quarter worth approximately $114,000. Teacher Retirement System of Texas acquired a new position in RadNet during the fourth quarter worth approximately $128,000. LPL Financial LLC acquired a new position in RadNet during the fourth quarter worth approximately $132,000. Alambic Investment Management L.P. acquired a new position in RadNet during the fourth quarter worth approximately $176,000. Finally, GSA Capital Partners LLP acquired a new position in RadNet during the first quarter worth approximately $177,000. 57.26% of the stock is currently owned by institutional investors.
RadNet Company Profile
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.